Ispaghula and Acetaminophen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ispaghula (blond psyllium) and Acetaminophen (acetaminophen). Common drug interactions include maternal exposure before pregnancy among females and sedation among males.

The phase IV clinical study analyzes what interactions people have when they take Ispaghula and Acetaminophen. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.

What is Ispaghula?

Ispaghula has active ingredients of blond psyllium. eHealthMe is studying from 737 Ispaghula users. Check the latest studies of Ispaghula.

What is Acetaminophen?

Acetaminophen has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 183,077 Acetaminophen users. Check the latest studies of Acetaminophen.



On Jul, 19, 2026

70 people who take Ispaghula and Acetaminophen together, and have interactions are studied.

Ispaghula and Acetaminophen drug interactions.

What are the common drug interactions of Ispaghula and Acetaminophen, by gender? *:

female:

  1. Maternal exposure before pregnancy (use of substance before pregnancy)
  2. Oedema peripheral (superficial swelling)
  3. Petechiae (a small red or purple spot caused by bleeding into the skin)
  4. Renal pain (kidney pain)
  5. Staphylococcal skin infection (skin infection by an infection with staphylococcus bacteria)
  6. Tendon rupture (tear of tendon)
  7. Toxic skin eruption (skin breakdown due to toxic substance)
  8. Vomiting
  9. Constipation
  10. Balance disorder

male:

  1. Sedation
  2. Pyrexia (fever)
  3. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  4. Myalgia (muscle pain)
  5. Oedema peripheral (superficial swelling)
  6. Rash erythematous (redness of the skin)
  7. Renal failure (kidney dysfunction)
  8. Peripheral swelling
  9. Hypoproteinaemia (too little prolactin circulating in the blood)
  10. Leukocytosis (increased white blood cells)

What are the common drug interactions of Ispaghula and Acetaminophen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  3. Arthralgia (joint pain)
  4. Ascites (accumulation of fluid in the abdominal cavity)
  5. Choluria (presence of bile in urine)
  6. Diarrhoea
  7. Hepatic failure (liver failure)
  8. Hepatomegaly (abnormal enlargement of the liver)
  9. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  10. Myalgia (muscle pain)

40-49:

  1. Dyspepsia (indigestion)
  2. Fear of eating
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Hypertension (high blood pressure)
  5. Pyrexia (fever)
  6. Rectal haemorrhage (bleeding from anus)
  7. Weight increased
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Back pain
  10. Dehydration (dryness resulting from the removal of water)

50-59:

  1. Blood osmolarity decreased
  2. Burning sensation
  3. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

60+:

  1. Sedation
  2. Fall
  3. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  4. Bladder disorder
  5. Dementia (madness)
  6. Dyspnoea (difficult or laboured respiration)
  7. Restlessness (not able to rest)
  8. Drug abuse
  9. Overdose
  10. Bradycardia (abnormally slow heart action)

What are the existing conditions these people have? *

  1. Bladder Disorder: 22 people, 31.43%
  2. Urinary Tract Infection: 21 people, 30.00%
  3. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 21 people, 30.00%
  4. Gastric Ulcer (stomach ulcer): 19 people, 27.14%
  5. Chest Pain: 19 people, 27.14%
  6. Constipation: 19 people, 27.14%
  7. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 19 people, 27.14%
  8. Dementia (madness): 19 people, 27.14%
  9. Fibromyalgia (a long-term condition which causes pain all over the body): 19 people, 27.14%
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints): 19 people, 27.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ispaghula and Acetaminophen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ispaghula and Acetaminophen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ispaghula:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Acetaminophen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ispaghula and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acetaminophen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on blond psyllium and acetaminophen (the active ingredients of Ispaghula and Acetaminophen, respectively), and Ispaghula and Acetaminophen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: